| PERIOD ENDING | 31-Mar-09 | 30-Sep-08 | 30-Jun-08 | 31-Mar-08 | | Total Revenue | 2,720,200 | 1,406,900 | 1,792,100 | 3,289,700 | | Cost of Revenue | 1,654,800 | 791,900 | 1,121,800 | 2,248,500 | | | Gross Profit | 1,065,400 | 615,000 | 670,300 | 1,041,200 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 581,700 | 370,200 | 408,500 | 514,300 | | Non Recurring | (2,000) | (400) | (900) | (1,500) | | Others | 143,800 | 141,000 | 147,700 | 135,600 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 341,900 | 104,200 | 115,000 | 392,800 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,000) | 20,800 | 1,300 | (1,500) | | Earnings Before Interest And Taxes | 347,300 | 128,400 | 117,900 | 393,300 | | Interest Expense | 90,500 | 100,200 | 87,400 | 91,800 | | Income Before Tax | 256,800 | 28,200 | 30,500 | 301,500 | | Income Tax Expense | 97,500 | (4,200) | 9,500 | 112,100 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 159,300 | 32,400 | 21,000 | 189,400 | | | Non-recurring Events | | Discontinued Operations | (10,900) | (12,400) | (223,300) | (90,100) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 148,400 | 20,000 | (202,300) | 99,300 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $148,400 | $20,000 | ($202,300) | $99,300 |
|
0.45% Nasdaq 
0.20%
Income Statement
